The effect of renin-angiotensin system inhibitors on kidney allograft survival: A systematic review and meta-analysis
Conclusion: This meta-analysis demonstrated insignificant reduced risks of renal graft loss among renal transplant recipients who received RAS inhibitors. Future studies assessing the potential benefits of RAS inhibitors on allograft survival in specific kidney transplant patient populations are needed.
Source: North American Journal of Medical Sciences - Category: General Medicine Authors: Wisit Cheungpasitporn Charat Thongprayoon Michael A Mao Wonngarm Kittanamongkolchai Insara J. J. Sathick Stephen B Erickson Source Type: research
More News: Bone Graft | Chronic Kidney Disease | Diabetes | Endocrinology | General Medicine | Kidney Transplant | Kidney Transplantation | Study | Transplant Surgery | Transplants | Urology & Nephrology | USA Health